Publicada a RDC Anvisa. 371 que altera RDC n° 370, de 13 de abril de 2020, que dispõe sobre a autorização prévia para fins de exportação de matéria-prima, produto semi-elaborado, produto a granel ou produto farmacêutico acabado destinados ao combate da COVID-19 / Anvisa RDC published. 371 amending RDC n ° 370, of April 13, 2020, which provides for prior authorization for the purpose of exporting raw materials, semi-finished products, bulk products or finished pharmaceutical products intended to combat COVID-19
Brasília; CONASS; abr. 2020. (CONASS informa, 191).
Monography
ي Pt
| CONASS, LILACS
| ID: biblio-1100566
المكتبة المسؤولة:
BR1.1
النص الكامل:
1
الفهرس:
LILACS
الموضوع الرئيسي:
Pneumonia, Viral
/
Pharmaceutical Preparations
/
Quarantine
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
اللغة:
Pt
مجلة:
CONASS informa
السنة:
2020
نوع:
Monography